Transdermal therapeutic systems of drug delivery
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
A review of existing transdermal therapeutic systems of drug delivery is presented. The advantages and disadvantages of these systems and t he dominating ways of development and creation of most advanced forms of medicines are shown.
About the Authors
V. V. Beregovikh
Первого МГМУ им. И.М. Сеченова
Russian Federation
Russian Federation
N. V. Pyatigorskaya
НИИ Фармации Первого МГМУ им. И.М. Сеченова
Russian Federation
Russian Federation
Yu. A. Prudkevich
МИТХТ им. М.В. Ломоносова
Russian Federation
Russian Federation
S. A. Kedik
МИТХТ им. М.В. Ломоносова
Russian Federation
Russian Federation
References
1. Vasil'ev A.E., Krasnyuk I.I., Ravikumar S., Tokhmakhchi V.N. Transdermal'nye terapevticheskie sistemy dostavki lekarstvennykh veshchestv (obzor) // Khim.-farm. zhurn. 2001. T. 35. S. 29-42.
2. Kharkevich D. A. Farmakologiya, 8-e izd. - M.: GEOTAR-Media, 2005.
3. Tokhmakhchi V.N., Vasil'ev A.E., Krasnyuk I.I., Rudakova I.P., Somov D.V., Samylina I.A. Razrabotka proekta obshchei farmakopeinoi stat'i «Transdermal'nye terapevticheskie sistemy» // Farmatsiya. 2008. № 3. S. 3-6.
4. Krivosheev C.A., Devyatkina I.A., Demina N.B. Applikatsionnye lekarstvennye formy: plastyri: uchebn. posobie / Pod obshch. red. V.A. Bykova. - M.: MAKS Press, 2005. 104 s.
5. Kattsung B. G. Bazisnaya i klinicheskaya farmakologiya. T. 2. - M.- SPb.: Binom-Nevskii dialekt, 1998. S. 61-88.
6. Belousov Yu.B. Transdermal'nye terapevticheskie sistemy // Kachestvennaya klinicheskaya praktika. 2001. № 1. S. 2-7.
7. Mizina P.G., Bykov V.A., Nastina Yu.I., Fomenko E.A. Vvedenie lekarstvennykh veshchestv cherez kozhu - dostizheniya i perspektivy (obzor) // Vestnik VGU. Ser.: Khimiya. Biologiya. Farmatsiya. 2004. S. 176-183.
8. Bagirova V.L., Demina K.B., Devyatkina I.A. [i dr.] Sovremennye aspekty ispol'zovaniya vspomogatel'nykh veshchestv v tekhnologii lekarstvennykh preparatov // Farmateka. 1998. № 6. S. 34-36.
9. Druz' E.A. (Morina E.A.), Fel'dman N.B., Lutsenko S.V. Transdermal'nye terapevticheskie sistemy s rastitel'nymi bioflavonoidami / Sb. materialov XVII Ros. natsional'nogo kongressa «Chelovek i lekarstvo», Moskva, 12-16 aprelya 2010. - M.: ZAO RITs «Chelovek i lekarstvo», 2010. S. 608.
10. Watson Pharmaceuticals, Inc, Corona. Compositions and methods for transdermal oxybutynin therapy: pat. SShA № 7179483 V2, opubl. 20.02.2007.
11. Hisamitsu Pharmaceutical Co. Adhesive patch: zayavka EPV, № 1 541 176A1, opubl. 15.06.2005.
12. Tengiz kamb Bert Uve Khartmann, Yakobashvili T. Sh. Sposob polucheniya preparata i preparat dlya transdermal'nogo vvedeniya nikotina: pat. 2263503S1 RF. - № 2004112288/15; zayavl. 23.04.2004; opubl. 10.11.2005, Byul. № 31.
13. Katritzky A.R., Dobchev D.A., Fara D.C., Hur E., Solov’ev V.P. Skin permeation rate as a function of chemical structure // J. Med. Chem. 2006. V. 49. № 11. P. 3305-3314.
14. Krishnaiah Y.S.R., Al-Saidan S.M., Jayaram B. Effect of nerodiol, carvone and anethole on the in vitro transdermal delivery of selegiline hydrochloride // Pharmazie. 2006. V. 61. № 1. P. 46-53.
15. SSP Co., Chuo-ku. Transdermal absorption preparation: zayavka EPV № 1522316 A1, opubl. 13.04.2005.
16. Hua L., Weisan P., Jiayu L., Ying Z. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery // Drug Development & Industrial Pharmacy. 2004. V. 30. № 6. P. 657-666.
17. Maffei P., Sforzini A., Borgia S., Ronchi C., Festo N. Design and evaluation of a new transdermal formulation containing estradiol // Pharm. Ind. 2003. V. 65. № 12. P. 1279-1282.
18. Takada, Yasunori, Hisamitsu Pharmaceutical Co. Percutaneous absorption type plaster: zayavka EPV № 1 477 164 A1, opubl. 17.11.2004.
19. Yoshinaga, Takaaki, Hisamitsu Pharmaceutical Co. Lowly irritative adhesive patch: zayavka EPV № 1 666 032 A1, opubl. 07.06.2006.
20. Schering AG. Transdermales pflaster mit Progesteron: zayavka Germanii № 102004 062182, opubl. 06.09.2006.
21. Prajapati S.T., Patel C.G., Patel C.N. Formulation and evaluation of transdermal patch of repaglinide // ISRN Pharmaceutics. 2011. 2011:9. Pages 651909.
22. Langguth T., Schumacher J., Susse M. UV-stabiles transdermales plaster: zayavka EPV № 1 452 173, opubl. 01.09.2004.
23. Schering AG. UV-Licht stabile halbfeste transdermale system: zayavka EPV № 1 541136, opubl. 15.06.2005.
24. Langguth T., Bracht S. Festes transdermales therapeutisches system mit UV-absorber: zayavka EPV, № 1 719 504, opubl. 08.11.2006.
25. Taogosei Co, Minato-ku, Nagoya-shi. Active energy radiation hardenable skin plaster composition and skin plaster: zayavka EPV № 1658 861, opubl. 24.05.2006.
26. Chueshov V.I. Promyshlennaya tekhnologiya lekarstv. T. 2 - Khar'kov: MTK-Kniga; Izd-vo NFAU, 2002. 716 s.
Review
For citations:
Beregovikh V.V., Pyatigorskaya N.V., Prudkevich Yu.A., Kedik S.A. Transdermal therapeutic systems of drug delivery. Fine Chemical Technologies. 2012;7(5):17-22. (In Russ.)
Views:
742
ISSN 2410-6593 (Print)
ISSN 2686-7575 (Online)
ISSN 2686-7575 (Online)
Email this article 
